Marine Drugs
Marine Drugs
Marine Drugs, a journal on the research, development and production of drugs from the sea, including marine natural product chemistry: ISSN 1660-3397 (electronic), CODEN: MDARE6, Journal DOI: 10.3390/md. It is published online quarterly. Copyright © 2003-2008 by MDPI. According to ISO-4 regulation, the abbreviated title of this journal is Mar. Drugs.
Marine Drugs is abstracted very rapidly by Chemical Abstracts, Cambridge Scientific Abstracts (CSA), Thomson Reuters Science Citation Index Expanded (SCI, including Web of Knowledge, Web of Science, Journal Citation Report and other Thomson Reuters products; since 2005), Biochemistry & Biophysics Citation Index, PubMed Central Archive (since 2007), PubMed/MEDLINE (since 2007) and EMBASE.
Impact Factor: the first impact factor for Marine Drugs is 1.103 in 2007.
* MDPI launched a new publication platform at www.mdpi.com.
* Open Access - free for readers, with low publishing fees paid by authors or their institutions. The open access publishing fees are 1000 CHF (Swiss Francs) per paper for well-written papers and 1250 CHF in total per paper for those papers that require extensive additional formatting and/or English corrections. The recent increase in the processing charges for Marine Drugs is due to the necessity of producing full-text XML versions of the articles for archiving in PubMed Central, and making articles searchable in PubMed. Marine Drugs deposits a full-text copy of each published article with PubMed Central in accord with the NIH Public Access Policy (will be done by the Marine Drugs Editorial Office).
* Rapid publication: accepted papers are immediately published. Well-written papers have been reviewed and published within 6 weeks.
http://www.mdpi.net/marinedrugs/
Marine Drugs, a journal on the research, development and production of drugs from the sea, including marine natural product chemistry: ISSN 1660-3397 (electronic), CODEN: MDARE6, Journal DOI: 10.3390/md. It is published online quarterly. Copyright © 2003-2008 by MDPI. According to ISO-4 regulation, the abbreviated title of this journal is Mar. Drugs.
Marine Drugs is abstracted very rapidly by Chemical Abstracts, Cambridge Scientific Abstracts (CSA), Thomson Reuters Science Citation Index Expanded (SCI, including Web of Knowledge, Web of Science, Journal Citation Report and other Thomson Reuters products; since 2005), Biochemistry & Biophysics Citation Index, PubMed Central Archive (since 2007), PubMed/MEDLINE (since 2007) and EMBASE.
Impact Factor: the first impact factor for Marine Drugs is 1.103 in 2007.
* MDPI launched a new publication platform at www.mdpi.com.
* Open Access - free for readers, with low publishing fees paid by authors or their institutions. The open access publishing fees are 1000 CHF (Swiss Francs) per paper for well-written papers and 1250 CHF in total per paper for those papers that require extensive additional formatting and/or English corrections. The recent increase in the processing charges for Marine Drugs is due to the necessity of producing full-text XML versions of the articles for archiving in PubMed Central, and making articles searchable in PubMed. Marine Drugs deposits a full-text copy of each published article with PubMed Central in accord with the NIH Public Access Policy (will be done by the Marine Drugs Editorial Office).
* Rapid publication: accepted papers are immediately published. Well-written papers have been reviewed and published within 6 weeks.
http://www.mdpi.net/marinedrugs/
Labels: Open access journals
posted by Anand Kumar Reddy at
9:51 PM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home